Jim Simons
SRTA

Jim Simons’s Strata Critical Medical Inc SRTA Stock Holding History

Jim Simons’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.99M Sell
474,886
-123,900
-21% -$596K ﹤0.01% 1900
2025
Q4 		$2.88M Buy
598,786
+400
+0.1% +$1.94K ﹤0.01% 1649
2025
Q3 		$3.03M Sell
598,386
-113,300
-16% -$501K ﹤0.01% 1787
2025
Q2 		$2.87M Buy
711,686
+121,647
+21% +$396K ﹤0.01% 1882
2025
Q1 		$1.61M Buy
590,039
+206,853
+54% +$742K ﹤0.01% 2131
2024
Q4 		$1.63M Buy
383,186
+85,486
+29% +$325K ﹤0.01% 2182
2024
Q3 		$875K Buy
297,700
+6,400
+2% +$20.4K ﹤0.01% 2526
2024
Q2 		$1.01M Buy
291,300
+46,600
+19% +$155K ﹤0.01% 2307
2024
Q1 		$697K Buy
244,700
+49,300
+25% +$152K ﹤0.01% 2703
2023
Q4 		$690K Sell
195,400
-194,799
-50% -$559K ﹤0.01% 2609
2023
Q3 		$1.01M Buy
390,199
+182,699
+88% +$642K ﹤0.01% 2286
2023
Q2 		$818K Buy
207,500
+61,400
+42% +$195K ﹤0.01% 2587
2023
Q1 		$494K Buy
146,100
+44,717
+44% +$182K ﹤0.01% 2897
2022
Q4 		$363K Buy
101,383
+53,783
+113% +$230K ﹤0.01% 3132
2022
Q3 		$192K Buy
47,600
+26,000
+120% +$134K ﹤0.01% 3398
2022
Q2 		$96K Buy
+21,600
New +$156K ﹤0.01% 3862

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jim Simons's SRTA Position: Q1 2026 in Review

Jim Simons reduced its Strata Critical Medical Inc (SRTA) stake by 21% in Q1 2026, selling an estimated $596K and leaving 474,886 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1900.

Jim Simons first reported a position in SRTA in Q2 2022 and has held it in 16 quarters since. The position peaked at $3.03M in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Jim Simons held 474,886 shares of Strata Critical Medical Inc worth $1.99M as of Q1 2026.
  • Jim Simons sold 123,900 Strata Critical Medical Inc shares in Q1 2026, an estimated $596K.
  • Strata Critical Medical Inc made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #1900 holding.
  • Jim Simons first reported a position in Strata Critical Medical Inc in Q2 2022 and has held it in 16 quarters since.
  • Jim Simons's Strata Critical Medical Inc position peaked at $3.03M in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.